mitoxantrone has been researched along with Abnormal Karyotype in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Abnormal Karyotype: A variation from the normal set of chromosomes characteristic of a species.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, YL | 1 |
| Chia, WK | 1 |
| Yap, EC | 1 |
| Julia, MI | 1 |
| Leong, CF | 1 |
| Salwati, S | 1 |
| Wong, CL | 1 |
1 other study available for mitoxantrone and Abnormal Karyotype
| Article | Year |
|---|---|
Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Humans; Idarubicin; In Situ Hybr | 2016 |